March 15, 2023 -- InvestorsHub NewsWire -- Via Stock Day Media -- At Stock Day
Media, we've named Rennova Health, Inc. (RNVA)
as one of the most undervalued stocks of 2023 on the OTC Markets.
From its low stock price to its positive cash flow and significant
revenue potential, investors will want to learn more about this
uniquely positioned company in the healthcare industry.
About Rennova, Health Inc.
Headquartered in West Palm Beach, Florida, Rennova Health, Inc.
is a company dedicated to delivering efficient, innovative, and
accessible healthcare services to rural communities. Rennova
currently owns one operating hospital, Big South Fork Medical
Center, located in Oneida and a rural clinic in Kentucky,
Tennessee, as well as an additional hospital and a physician's
practice located in Jamestown, Tennessee, which are both slated to
reopen.
Rennova has recently taken strides to further diversify its
offerings. With the formation of Myrtle Recovery Centers, Rennova
will also be able to provide comprehensive care for individuals
with substance, behavioral, and mental health challenges as the
demand for these services continues to grow.
Rennova also made the decision to separate its former technology
and software division into InnovaQor, Inc. (INQR), a company
dedicated to creating innovative technology solutions that allow
medical providers and facilities to effectively enhance their
business and processes, while protecting their assets and patient
data.
Share Structure and Revenue Potential
Currently, we estimate that Rennova Health, Inc. is now
generating in excess of $15 million in revenues annually from its
Big South Fork Medical Center with a positive cash flow on a
monthly basis. Rennova is expected to continue growing its revenues
and could add another $10 million annually from its Myrtle Recovery
Centers division, which it expects to open in the second quarter.
Additionally, with the capacity for 25 medical beds, 40 mental
health beds, plus operational surgical facilities, Rennova is
targeting a 2024 reopening of its Jamestown, Tennessee regional
hospital. This hospital previously had revenues of approximately
$1.2 to $1.5 million per month.
Yet, despite its positive cash flow, proven revenue generation,
and the potential for significant revenue additions, Rennova
Health, Inc. is currently a triple zero stock with a market cap of
just $3 million, earning the company a spot as one of Stock Day's
most undervalued stocks of 2023.
InnovaQor Investment
However, none of the above includes Rennova Health. Inc.'s
significant investment in its former technology and software
division, InnovaQor, Inc., which is now a fully reporting public
company trading on the OTC Markets under the ticker symbol 'INQR'.
At Stock Day Media, we believe this investment could provide
additional returns for Rennova, and it has previously been
intimated that Rennova shareholders may receive shares in InnovaQor
from Rennova.
While InnovaQor continues its efforts to raise funding to
execute on its business plans, the company has published
significant news regarding the securement of a signed agreement
with XCPCNL Business Services Corporation (OTC:XCPL) to develop a
sales and marketing strategy for its healthcare software products
and services. On February 28th, 2023, InnovaQor also announced the
launch of its automated billing solution through its subsidiary,
Medical Mime, Inc., a provider of an EHR (Electronic Health
Records) software designed for behavioral health and substance
abuse facilities.
Market Demand
In determining their business model and diversification
strategy, it is clear that Rennova Health, Inc. is well positioned
to meet not only the needs of its communities but also the evolving
demands of the healthcare industry.
According to the American Hospital Association, nearly 20% of
Americans live in rural areas and depend on their hospitals as
important – and often only – sources of care in their communities.
Meanwhile, The U.S. behavioral health market size was valued at USD
76.44 billion in 2021 and is projected to grow from USD 79.69
billion in 2022 to USD 105.14 billion by 2029, according
to Fortune
Business Insights.
For Rennova, the proven demand for improved access to rural
healthcare, as well as the increasing need for behavioral health
services, adds both strength and opportunity to their business
strategy, representing significant potential for investors and
shareholders.
Learn More About Rennova, Health Inc. (RNVA)
Today!
With its triple zero status, significant revenues, and positive
cash flow, it's easy to see why we've named Rennova Health, Inc. as
one of 2023's most undervalued stocks. However, with a number of
exciting projects set to launch this year, it is Rennova's upcoming
revenue potential and diversified offerings that makes this company
a blatant standout among other companies listed on the OTC Market
in the healthcare services industry.
To learn more about this undervalued stock, please visit
Stock Day
Media or listen to Rennova's latest podcast interview,
here.
SOURCE: Stock Day Media
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Nov 2023 to Nov 2024
